Poly Medicure Limited has announced that its board will meet on February 5, 2026, to consider and approve the unaudited financial results for the Third Quarter and Nine Months ended December 31, 2025. This announcement follows the company’s previous intimation regarding the closure of the trading window, which will remain closed until February 7, 2026.
Board Meeting Announcement
The Board of Directors of Poly Medicure Limited is scheduled to convene a meeting on February 5, 2026. The primary agenda of the meeting is to review and approve the company’s unaudited financial performance.
Financial Results Consideration
During the meeting, the board will specifically address the unaudited financial results (both consolidated and standalone) for Q3 (Oct-Dec) and the nine-month period ending on December 31, 2025. This is a key event for investors and stakeholders looking for insights into the company’s recent financial health and performance.
Trading Window Closure
As previously announced, the trading window for company securities remains closed. This closure, which began earlier, will continue until February 7, 2026. This measure ensures compliance and prevents any potential insider trading during the sensitive period leading up to the financial results announcement.
Source: BSE
